SYNTHESIS AND PHARMACOLOGICAL EXAMINATION OF BENZOFURAN, INDAN, AND TETRALIN ANALOGS OF 3,4-(METHYLENEDIOXY)AMPHETAMINE

被引:73
作者
MONTE, AP
MARONALEWICKA, D
COZZI, NV
NICHOLS, DE
机构
[1] PURDUE UNIV, SCH PHARM & PHARMACAL SCI, DEPT MED CHEM & PHARMACOGNOSY, W LAFAYETTE, IN 47907 USA
[2] PURDUE UNIV, SCH PHARM & PHARMACAL SCI, DEPT PHARMACOL & TOXICOL, W LAFAYETTE, IN 47907 USA
关键词
D O I
10.1021/jm00075a027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzofuran, indan and tetrahydrohaphthalene analogs of 3,4-(methylenedioxy)amphetamine (MDA) were prepared in order to examine the role of the dioxole ring oxygen atoms of MDA in interacting with the serotonin and catecholamine uptake carriers. The series of compounds was evaluated for discriminative stimulus effects in rats trained to discriminate saline from the training drugs (S)-(+)-MBDB (1c), MMAI (3), and (S)-(+)-amphetamine and for the ability to inhibit the uptake of [H-3]serotonin, [H-3]dopamine, and [H-3]norepinephrine into crude synaptosome preparations. Behaviorally, the benzofuran and indan analogs 4-6 produced similar discriminative cues, whereas the tetralin derivative 7 did not fully substitute for the training drugs. The results in the in vitro pharmacology studies indicate that selectivity for 5-HT versus catecholamine uptake carriers may be modulated by the position and orientation of ring oxygen atoms. However, the nonoxygenated isostere 6 possessed high potency at all uptake sites examined. Enlargement of the saturated ring by one methylene unit to give the tetralin derivative resulted in a large (3-4-fold) reduction in activity at catecholamine sites.
引用
收藏
页码:3700 / 3706
页数:7
相关论文
共 33 条
[1]  
ANDERSON GM, 1978, NATIONAL I DRUG ABUS, V22, P27
[2]  
Eggler J.F., 1987, Patent No. [US 4703052 A, 4703052]
[3]   INTERACTIONS OF METHYLENEDIOXYMETHAMPHETAMINE WITH MONOAMINE TRANSMITTER RELEASE MECHANISMS IN RAT-BRAIN SLICES [J].
FITZGERALD, JL ;
REID, JJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (03) :313-323
[4]   SUBJECTIVE REPORTS OF THE EFFECTS OF MDMA IN A CLINICAL SETTING [J].
GREER, G ;
TOLBERT, R .
JOURNAL OF PSYCHOACTIVE DRUGS, 1986, 18 (04) :319-327
[5]   ANTIOXIDANT-BASED INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS - THE DISCOVERY OF 6-[1-[2-(HYDROXYMETHYL)PHENYL]-1-PROPEN-3-YL]-2,3-DIHYDRO-5-BENZOFURANOL, A POTENT TOPICAL ANTIINFLAMMATORY AGENT [J].
HAMMOND, ML ;
ZAMBIAS, RA ;
CHANG, MN ;
JENSEN, NP ;
MCDONALD, J ;
THOMPSON, K ;
BOULTON, DA ;
KOPKA, IE ;
HAND, KM ;
OPAS, EE ;
LUELL, S ;
BACH, T ;
DAVIES, P ;
MACINTYRE, DE ;
BONNEY, RJ ;
HUMES, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :908-918
[6]  
HUANG X, 1993, IN PRESS EUR J PHARM
[7]   SYNTHESIS AND PHARMACOLOGICAL EXAMINATION OF 1-(3-METHOXY-4-METHYLPHENYL)-2-AMINOPROPANE AND 5-METHOXY-6-METHYL-2-AMINOINDAN - SIMILARITIES TO 3,4-(METHYLENEDIOXY)METHAMPHETAMINE (MDMA) [J].
JOHNSON, MP ;
FRESCAS, SP ;
OBERLENDER, R ;
NICHOLS, DE .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (05) :1662-1668
[8]   SEROTONIN NEUROTOXICITY IN RATS AFTER COMBINED TREATMENT WITH A DOPAMINERGIC AGENT FOLLOWED BY A NONNEUROTOXIC 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOG [J].
JOHNSON, MP ;
HUANG, X ;
NICHOLS, DE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) :915-922
[9]   [H-3] MONOAMINE RELEASING AND UPTAKE INHIBITION PROPERTIES OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND PARA-CHLOROAMPHETAMINE ANALOGS [J].
JOHNSON, MP ;
CONARTY, PF ;
NICHOLS, DE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (01) :9-16
[10]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99